macular degeneration glp 1 We found that GLP-1 receptor agonists were associated with a lower risk of age-related (especially dry AMD) in adults with diabetes and obesity compared with metformin or other weight-loss medications. # GLP-1 Agonists May Lower Risk
Description
Data was extracted using a standardized form that included the following information: author, year and country of study, study design and population, key outcomes and results, main conclusions
And users who can't get insurance coverage, may be able to get the drug for as low as $550 a month
That doesn't mean lower doses never work
Sehgal P, Lewis JD, Pickett-Blakely O, Nandi N, Bewtra M, Lichtenstein GR
The results showed high heterogeneity of weight loss from the baseline weight between individuals even at the highest dose of tirzepatide 38.4 to 9.0 kg and mean 22.1 kg
